Cheryl A. Rizzo - Concepedia

Author

Cheryl A. Rizzo

Bristol-Myers Squibb (United States)

Also Known As

C A Rizzo, C Rizzo, C. A. Rizzo, Cheryl A Rizzo, Cheryl A. Rizzo, Cheryl Rizzo

Publications

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Albany Molecular Research (United States)

About

Cheryl A. Rizzo is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.2K
2	Natural Sciences	6	6	278
3	Biochemistry	4	4	120
4	Cell Biology	3	3	236
5	Chemistry	2	2	72

Cheryl A. Rizzo

Publications

Citations

H-Index

Page 1

	Year	Citations
Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family Falk Weih, Daniel R. Carrasco, Stephen K. Durham, Cell ImmunologyImmune RegulationPathologyMultiorgan InflammationInnate Immunity	1995	801
Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses Jorge Caamaño, Cheryl A. Rizzo, Stephen K. Durham, The Journal of Experimental Medicine	1998	394
The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens Liang Schweizer, Cheryl A. Rizzo, Thomas Spires, BMC Cell Biology	2008	114
Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts. P Dobrazanski, T Noguchi, Karla Kovary, Molecular and Cellular Biology Molecular BiologyShort FormTranscriptional RegulationSignaling PathwayCell Regulation	1991	97
The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist. Donald C. Bolser, David J. Blythin, Richard W. Chapman, Journal of Pharmacology and Experimental Therapeutics	1995	77
The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice. Daniel R. Carrasco, Cheryl A. Rizzo, Karen S. Dorfman, The EMBO Journal Tumor BiologyLymphoid NeoplasiaOncogenic AgentImmunologyTumor Immunity	1996	75
Expression of FosB during mouse development: normal development of FosB knockout mice. M C Gruda, Jan van Amsterdam, Cheryl A. Rizzo, PubMed	1996	74
Multiple Hemopoietic Defects and Lymphoid Hyperplasia in Mice Lacking the Transcriptional Activation Domain of the c-Rel Protein Daniel R. Carrasco, Janet Cheng, Anne Lewin, The Journal of Experimental Medicine Lymphocyte DevelopmentEnlarged SpleenImmunologyBlood CellMultiple Hemopoietic Defects	1998	64
Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists Mark Salvati, Aaron Balog, Weifang Shan, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryAndrogen Receptor AntagonistsMedicinal ChemistryHeterocyclicNatural Sciences	2004	61
Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer Ricardo M. Attar, Maria Jure–Kunkel, Aaron Balog, Cancer Research	2009	55

Page 1